8-K current report · filed Nov 2, 2026

Tempus AI Inc (TEM) 8-K Current Report: November 2, 2026

Item 2.02Item 7.01Item EX-99.1TEM overview

Short answer

Tempus AI Inc (TEM) filed an 8-K current report with the SEC on November 2, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 financial results for quarter ended September 30, 2026.

Tempus AI Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 2026 financial results for quarter ended September 30, 2026
  • Press release issued November 2, 2026, with detailed results in Exhibit 99.1

Item 7.01 · Regulation FD Disclosure

  • Supplemental financial information released for quarter ended September 30, 2026
  • CEO and CFO letter posted alongside quarterly materials
  • Investor-relevant updates available through Tempus AI’s investor relations website

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $411.5M, up 23%, led by Oncology volume growth of 32% and Data & Applications growth of 33%
  • Gross profit $266.7M, up 27%, with gross margin expanding to 64.8% from 62.8%
  • Adjusted EBITDA $25.6M versus $1.5M, signaling materially improved operating leverage despite a $14.9M GAAP net loss
  • FY2026 revenue guidance raised to $1.60-$1.605B, with Adjusted EBITDA guidance maintained at approximately $65M
  • Data licensing bookings exceeded $550M year to date, while BMS agreements include up to $192.5M over five years across oncology and Alzheimer's data

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Tempus AI Inc 8-K filings

Get the next TEM 8-K as it lands

Follow TEM for push alerts, or ask the research agent what this filing means.